Back to comparisons

Comparison

Bacopa Monnieri vs Honokiol (Magnolia Bark)

FieldBacopa MonnieriHonokiol (Magnolia Bark)
Categoryadaptogenadaptogen
Dose range300–600mg250–1000mg
Half-life4h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs540600

The comparison in plain English

Auto-generated from data

Bacopa Monnieri and Honokiol (Magnolia Bark) are both in the adaptogen category respectively. Bacopa Monnieri Ayurvedic herb (Bacopa monnieri) with the strongest natural-nootropic evidence base for memory acquisition and retention. Honokiol (Magnolia Bark) Bioactive lignan from Magnolia bark.

Bottom line

Bacopa Monnieri (evidence A, safety 5/5) has a weaker evidence base than Honokiol (Magnolia Bark) (evidence B, safety 4/5). Bacopa Monnieri has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Bacopa Monnieri if

Bacopa Monnieri is the better fit when your goal aligns with its mechanism (Active bacosides A and B increase dendritic branching in the CA3 region of the hippocampus, the structural change that underlies improved memory consolidation) and the dose range (300–600mg) suits your protocol. Half-life is 4h.

Choose Honokiol (Magnolia Bark) if

Honokiol (Magnolia Bark) is the better fit when your goal aligns with its mechanism (Honokiol and magnolol are positive allosteric modulators of GABA-A receptors at sites distinct from benzodiazepines) and the dose range (250–1000mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →